rs104894226
|
|
Mammary Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104894228
|
|
Mammary Neoplasms
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104894228
|
|
Mammary Neoplasms
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104894228
|
|
Mammary Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104894229
|
|
Mammary Neoplasms
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104894229
|
|
Mammary Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057517590
|
|
Mammary Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Nonsense-mediated mRNA decay: terminating erroneous gene expression.
|
15145354 |
2004 |
rs1057518635
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1057518636
|
|
Mammary Neoplasms
|
GA |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1057518637
|
|
Mammary Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1057518638
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1057519045
|
|
Mammary Neoplasms
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials.
|
22162582 |
2012 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.
|
18725974 |
2008 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
|
18676830 |
2008 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
|
15805248 |
2005 |
rs1057519699
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
The PIK3CA gene is mutated with high frequency in human breast cancers.
|
15254419 |
2004 |
rs1057519714
|
|
Mammary Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519715
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519716
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519717
|
|
Mammary Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
|
24185510 |
2013 |
rs1057519717
|
|
Mammary Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |